Summary

• Oklo is upgraded from Sell to Hold as prior risk factors—dilutive share issuance, regulatory delays, and non-binding pipeline—have moderated.
• OKLO's execution has improved: Groves reactor in Texas nears criticality, Aurora-INL advances, and the Meta partnership for a 1.2 GW Ohio campus signals momentum.
• Valuation remains stretched; the current price assumes aggressive execution, with meaningful upside only if multiple hurdles—regulatory, commercial, and operational—are cleared.
• A compelling Buy case emerges at $40-45 or with catalysts like Groves criticality, signed PPAs, or finalization of NRC Part 57 licensing.

In December 2025, I had downgraded Oklo (OKLO) to a Sell. That the stock looked expensive at that point is one half of the story. Additionally, three specific conditions made the risk-reward negative.

First, Oklo had

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.